1.
一站式组与匹配前后的房颤消融组的临床基线资料对比表
Baseline data of the patients in one-stop procedure group and AF ablation group before and after matching
| Baseline characteristics | One-stop procedure group (n=56) | Unmatched control group (n=375) | Matched control group (n=56) | P1 | P2 | |
| BMI: Body mass index; AF: Atrial fibrillation; CHD: Coronary heart disease; P1: P value before matching; P2: P value after matching. | ||||||
| Age (years) | 65.2±6.6 | 63.5±9.6 | 64.8±8.5 | 0.115 | 0.805 | |
| Male | 33 (58.9%) | 216 (57.6%) | 34 (60.7%) | 0.851 | 0.847 | |
| BMI (kg/m2) | 25.3±4.3 | 24.3±3.8 | 25.0±4.3 | 0.093 | 0.507 | |
| CHA2DS2-VASc score | 4.3±1.8 | 3.8±1.6 | 4.1±1.7 | 0.098 | 0.621 | |
| HAS-BLED score | 2.0±1.3 | 1.7±1.2 | 1.8±1.1 | 0.077 | 0.466 | |
| Duration of AF (month) | 40.7±47.4 | 47.3±88.9 | 55.6±100.9 | 0.287 | 0.815 | |
| AF Type | 0.024 | 0.493 | ||||
| Paroxysmal AF | 24 (42.9%) | 227 (60.5%) | 30 (53.6%) | - | - | |
| Persistent AF | 10(17.8%) | 60 (16.0%) | 7 (12.5%) | - | - | |
| Long-standing persistent AF | 22 (39.3%) | 88 (23.5%) | 19 (33.9%) | - | - | |
| Comorbidity | ||||||
| Hypertension | 39 (69.6%) | 158 (42.1%) | 39 (69.6%) | < 0.001 | 1.000 | |
| Diabetes | 13 (23.2%) | 60 (16.0%) | 11 (19.6%) | 0.179 | 0.645 | |
| CHD | 15 (26.8%) | 70 (18.7%) | 13 (23.2%) | 0.154 | 0.663 | |
| History of stroke | 17 (30.4%) | 86 (22.9%) | 18 (32.1%) | 0.224 | 0.838 | |